Alternative approaches to IP regulation
From PHM Oz
(Difference between revisions)
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | + | Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [[http://www.nhmrc.gov.au/funding/policy/_files/ipman.pdf web reference]]</br> | |
| − | + | Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [[http://www.globalizationandhealth.com/content/3/1/1 web link]]</br> | |
| − | + | Universities Allied for Essential Medicines [[http://www.essentialmedicine.org/ web link]]. Statement of Principles [[http://www.petitiononline.com/uaemuw/petition.html Principles]]</br> | |
| − | + | Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [[http://www.who.int/intellectualproperty/en/ Web link]]</br> | |
| − | + | Brewster et al (2005) [[http://www.biodevelopments.org/innovation/ist3.pdf Innovation Strategy Today]]</br> | |
| − | + | ICRISAT Policy on IPRs [[http://www.icrisat.org/ip_management/policy.htm IP management]]</br> | |
| − | + | Possible role for patent pooling in managing SARS [[http://www.who.int/bulletin/volumes/83/9/707.pdf Patent Pooling]]</br> | |
| − | + | Patent pools [[http://www.uspto.gov/web/offices/pac/dapp/opla/patentpool.pdf Patent Pools]]</br> | |
| − | + | Anti-commons in biomedical research [[http://0-find.galegroup.com.alpha2.latrobe.edu.au/itx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A20606179&source=gale&srcprod=EAIM&userGroupName=latrobe&version=1.0 Anticommons]]</br> | |
| − | + | ||
| − | Anti-commons in biomedical research [[http://0-find.galegroup.com.alpha2.latrobe.edu.au/itx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A20606179&source=gale&srcprod=EAIM&userGroupName=latrobe&version=1.0 Anticommons]] | + | |
| − | + | ||
| − | + | ||
| + | Stiglitz on the Medical Prize Fund [[http://www.bmj.com/cgi/content/full/333/7582/1279 BMJ]]</br> | ||
[[Intellectual Property and Pharmaceuticals|Back to IP home]]</br> | [[Intellectual Property and Pharmaceuticals|Back to IP home]]</br> | ||
[[PHM_Oz_IP_Project|IP Project Page]] | [[PHM_Oz_IP_Project|IP Project Page]] | ||
Revision as of 00:03, 11 July 2007
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [web reference]</br>
Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [web link]</br>
Universities Allied for Essential Medicines [web link]. Statement of Principles [Principles]</br>
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [Web link]</br>
Brewster et al (2005) [Innovation Strategy Today]</br>
ICRISAT Policy on IPRs [IP management]</br>
Possible role for patent pooling in managing SARS [Patent Pooling]</br>
Patent pools [Patent Pools]</br>
Anti-commons in biomedical research [Anticommons]</br>
Stiglitz on the Medical Prize Fund [BMJ]</br>
